Rocket Lab USA, Inc.

RKLB remains in a powerful multi-month uptrend and still trades well above its 200-day moving average, keeping the longer-term regime constructive. The stock is also well above its 52-week low of $25.24, though it has pulled back from the $151 high, so shareholders should watch whether momentum consolidates or resumes higher.

Street sentiment is constructive: the consensus is Buy, with 13 buys, 5 holds, and 1 sell. The average target sits near $99.88, below the latest close, while recent action has been mostly target raises and upgrades, including Stifel to $132 and Deutsche Bank to $120.

The earnings pattern is mixed but improving, with 4 beats in the last 7 quarters and the last three reported quarters all topping estimates. Next-year EPS is still expected near breakeven at -$0.039, so the key watch is whether revenue growth can keep outrunning losses and support another beat.

Recent activity leans to net selling on discretionary trades, led by director Alexander Slusky and COO Frank Klein. The CFO and another officer also received award and gift-related share movements, which are compensation noise rather than conviction signals; the only clear signal is that insiders have not been net buyers.

Profitability is still negative, but the top line is scaling fast: revenue growth is 63.5% year over year. Gross margin is 36.6%, while operating margin is -22.36% and net margin is -26.87%, so the setup favors execution on growth and a path toward leverage.

RKLB stands out for growth and optionality versus traditional aerospace peers, but it still trails on earnings quality and margin structure. The valuation remains rich on a sector basis, with a market cap above $62.6 billion and a negative earnings profile that leaves little room for execution slips.